All posts tagged "Regeneron Pharmaceuticals"
-
873BiotechAtea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals
The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...
-
2.5KBiotechCOVID Stocks Popping in Sympathy with Positive Humanigen Top Line Data
Humanigen Inc. (NASDAQ: HGEN) released excellent news that their drug lenzilumab improved survival without the need for invasive mechanical ventila...
-
4306BiotechLeronlimab Trial Results All But Certain Pointing to Approval For CytoDyn
CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...
-
3872BiotechWading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
-
295BiotechTop Coronavirus Stocks backed by Scientific Evidence
Developing a vaccine to treat COVID-19 is hands down the best way to play the long term coronavirus stocks. Ultimately a vaccine...
-
Stocks
Trending Tickers: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), American International Group, Inc. (NYSE:AIG), Myriad Genetics Inc. (NASDAQ:MYGN), Carlisle Companies (NYSE:CSL), Banc of California (NYSE:BANC)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) cut the top end of its sales forecast for the blockbuster eye drug Eylea, citing slower adoption by...
-
Stocks
Announcement Affects: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), SinoCoking Coal and Coke Chemical Industries, Inc. (NASDAQ:SCOK), Valeant Pharmaceuticals International, Inc. (NYSE:VRX)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi (SNY) released that the first patients have been dosed in a Phase 3 clinical study of...
-
Stocks
Trending Stocks : Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), Nektar Therapeutics (NASDAQ:NKTR), Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), United Microelectronics (NYSE:UMC), Schmitt Industries (NASDAQ:SMIT)
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Friday morning that EYLEA Injection demonstrated a significantly greater improvement in mean change in best-corrected visual acuity...
-
Stocks
Stocks In Focus: Telef (NYSE:TEF), Honeywell International Inc. (NYSE:HON), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Telefonica S.A. (ADR) (NYSE:TEF) declared that its plan to cut 1,600 full-time positions by 2018. The firm reported that the job reductions...